BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16669960)

  • 1. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
    D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC
    Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal permeability in patients with Crohn's disease and their first-degree relatives.
    Howden CW; Gillanders I; Morris AJ; Duncan A; Danesh B; Russell RI
    Am J Gastroenterol; 1994 Aug; 89(8):1175-6. PubMed ID: 8053430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for celiac disease in first-degree relatives of patients with celiac disease by lactulose/mannitol test.
    Vogelsang H; Wyatt J; Penner E; Lochs H
    Am J Gastroenterol; 1995 Oct; 90(10):1838-42. PubMed ID: 7572905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with ankylosing spondylitis and healthy relatives do not show increased small intestinal permeability with the lactulose-mannitol test.
    Kuiper S; van Pelt J; Verheesen PE; Rentsch HU; Stockbrügger R; van der Linden SM
    Clin Exp Rheumatol; 1993; 11(4):413-6. PubMed ID: 8403588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal permeability in patients with Crohn's disease and their first degree relatives.
    Teahon K; Smethurst P; Levi AJ; Menzies IS; Bjarnason I
    Gut; 1992 Mar; 33(3):320-3. PubMed ID: 1568650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal permeability in patients with Crohn's disease and their healthy relatives.
    Katz KD; Hollander D; Vadheim CM; McElree C; Delahunty T; Dadufalza VD; Krugliak P; Rotter JI
    Gastroenterology; 1989 Oct; 97(4):927-31. PubMed ID: 2506103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passage of molecules through the wall of the gastrointestinal tract. Intestinal permeability to polyethyleneglycol 1 000 in patients with Crohn's disease.
    Heuman R; Sjödahl R; Tagesson C
    Acta Chir Scand; 1982; 148(3):281-4. PubMed ID: 7136430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between lactulose-mannitol test and 51Cr-labelled ethylene diamine tetra-acetate test in inflammatory bowel diseases.
    Andre C; Descos L; Minaire Y
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():113-7. PubMed ID: 2128072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurement of selective intestinal permeability using a new, simple sugar absorption test].
    van Elburg RM; Kokke FT; Uil JJ; Mulder CJ; de Monchy JG; Heymans HS
    Ned Tijdschr Geneeskd; 1993 Oct; 137(41):2091-5. PubMed ID: 8413731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different measurements of intestinal permeability in inflammatory bowel disease.
    Howden CW; Robertson C; Duncan A; Morris AJ; Russell RI
    Am J Gastroenterol; 1991 Oct; 86(10):1445-9. PubMed ID: 1928036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives.
    Munkholm P; Langholz E; Hollander D; Thornberg K; Orholm M; Katz KD; Binder V
    Gut; 1994 Jan; 35(1):68-72. PubMed ID: 8307453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal permeability and the prediction of relapse in Crohn's disease.
    Wyatt J; Vogelsang H; Hübl W; Waldhöer T; Lochs H
    Lancet; 1993 Jun; 341(8858):1437-9. PubMed ID: 8099141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased gastrointestinal absorption of peroral polyethyleneglycols (PEG 1000) in Crohn's disease. A sign of jejunal abnormality.
    Olaison G; Sjödahl R; Tagesson C
    Acta Chir Scand; 1987; 153(5-6):373-7. PubMed ID: 3661039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease.
    Magnusson KE; Sundqvist T; Sjödahl R; Tagesson C
    Acta Chir Scand; 1983; 149(3):323-7. PubMed ID: 6613469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon.
    Ukabam SO; Clamp JR; Cooper BT
    Digestion; 1983; 27(2):70-4. PubMed ID: 6414866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial incidence of Crohn's disease in The Netherlands and a review of the literature.
    Weterman IT; Peña AS
    Gastroenterology; 1984 Mar; 86(3):449-52. PubMed ID: 6693011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal permeability in patients infected with the human immunodeficiency virus.
    Tepper RE; Simon D; Brandt LJ; Nutovits R; Lee MJ
    Am J Gastroenterol; 1994 Jun; 89(6):878-82. PubMed ID: 8198098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability.
    Yacyshyn BR; Meddings JB
    Gastroenterology; 1995 Jan; 108(1):132-7. PubMed ID: 7528696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial incidence of Crohn disease].
    Bürger L; Karoff C; Wagner H
    Fortschr Med; 1981 Mar; 99(10):340-1. PubMed ID: 7216099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives.
    Ainsworth M; Eriksen J; Rasmussen JW; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol; 1989 Oct; 24(8):993-8. PubMed ID: 2512633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.